Liraglutide plus metformin benefits T2D patients with NAFLD
Use of liraglutide in obese patients with type 2 diabetes (T2D) and nonalcoholic fatty liver disease (NAFLD) receiving metformin yields favourable effects on liver fat content and abdominal adiposity, with additional benefits of inducing weight loss and improving liver function, as compared with insulin glargine and placebo, a study reports.